George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Regulatory News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.19
Bid: 0.18
Ask: 0.20
Change: 0.00 (0.00%)
Spread: 0.02 (11.111%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.19
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Holdings

12 Feb 2020 16:10

RNS Number : 8166C
Nuformix PLC
12 February 2020
 

NTR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Nuformix Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Alan Chorlton

City and country of registered office (if applicable)

UK

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

18/11/2019

6. Date on which issuer notified (DD/MM/YYYY):

10/02/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

34,917,413

7.12%

490,145,083

Position of previous notification (if

applicable)

42,000,000

8.57%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BYW79Y38

34,917,413

7.12%

SUBTOTAL 8. A

34,917,413

7.12%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

x

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Wickhambrook, Newmarket, Suffolk, UK

Date of completion

10/02/2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLKKBBKABKDFBD
Date   Source Headline
1st Feb 20227:00 amRNSAdviser Appointments
31st Jan 20222:09 pmRNSDirector/PDMR Shareholding
31st Jan 202211:05 amRNSResult of General Meeting
17th Jan 20229:56 amRNSPosting of Circular and Notice of General Meeting
10th Jan 20224:23 pmRNSDirector/PDMR Shareholding
21st Dec 20217:00 amRNSHolding(s) in Company
14th Dec 20212:05 pmRNSSecond Price Monitoring Extn
14th Dec 20212:00 pmRNSPrice Monitoring Extension
14th Dec 20217:01 amRNSSubscription to raise £1.65 million
14th Dec 20217:00 amRNSHalf year Report
25th Nov 20217:00 amRNSPositive pre-clinical data on NXP002
17th Nov 20219:34 amRNSHolding(s) in Company
12th Nov 20217:00 amRNSNXP004 patent application filing
9th Nov 20217:00 amRNSDirectorate Change
4th Oct 20212:01 pmRNSPrice Monitoring Extension
16th Sep 20212:14 pmRNSDirector/PDMR Shareholding - Replacement
16th Sep 202112:47 pmRNSDirector/PDMR Shareholding
13th Sep 20217:00 amRNSLicensing agreement with Oxilio for NXP001
24th Aug 202111:57 amRNSResult of AGM
23rd Jul 20211:35 pmRNSPosting of Annual Report and Notice of AGM
22nd Jul 20217:00 amRNSLetter to shareholders re: Dr Anne Brindley
21st Jul 20214:41 pmRNSSecond Price Monitoring Extn
21st Jul 20214:36 pmRNSPrice Monitoring Extension
21st Jul 20217:00 amRNSDirectorate Change
15th Jul 20217:00 amRNSFinal results for the year ended 31 March 2021
10th Jun 20219:25 amRNSHolding(s) in Company
7th Jun 20217:00 amRNSNotice of Allowance of Patent in US
1st Jun 20217:00 amRNSProject update - Progress on NXP002 and NXP004
24th May 20217:00 amRNSDirectorate Changes
12th May 202111:35 amRNSHolding(s) in Company
11th May 20211:51 pmRNSHolding(s) in Company
22nd Apr 20212:06 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:00 pmRNSPrice Monitoring Extension
8th Apr 20213:30 pmRNSCorrection: Holding(s) in Company
8th Apr 202111:54 amRNSHolding(s) in Company
6th Apr 202110:38 amRNSHolding(s) in Company
30th Mar 20215:14 pmRNSHolding(s) in Company
29th Mar 202111:27 amRNSResult of General Meeting and Total Voting Rights
22nd Mar 20217:00 amRNSNXP001 (Oncology) - Exercise of Option by Oxilio
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:36 pmRNSPrice Monitoring Extension
19th Mar 202111:05 amRNSSecond Price Monitoring Extn
19th Mar 202111:00 amRNSPrice Monitoring Extension
19th Mar 20219:05 amRNSSecond Price Monitoring Extn
19th Mar 20219:00 amRNSPrice Monitoring Extension
11th Mar 20217:00 amRNSInitiation of research by Allenby Capital
10th Mar 202111:05 amRNSSecond Price Monitoring Extn
10th Mar 202111:00 amRNSPrice Monitoring Extension
10th Mar 20219:05 amRNSSecond Price Monitoring Extn
10th Mar 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.